New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For LLY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 22, 2014
11:09 EDTLLYFTC puts conditions on Lilly's proposed acquisition of Novartis Animal Health
Global pharmaceutical company Eli Lilly and Company (LLY) has agreed to divest its Sentinel product line of medications for treating heartworm disease in dogs in order to settle FTC charges that its proposed $5.4B acquisition of Novartis (NVS) Animal Health would likely be anticompetitive. Under the proposed settlement, Eli Lilly will divest its Sentinel product line and associated assets to the French pharmaceutical company, Virbac. Indianapolis-based Eli Lilly, through its Elanco Animal Health division, and Switzerland-based Novartis AGs Novartis Animal Health business unit both develop and market a wide range of animal health products, including medications to treat diseases and conditions affecting pets and livestock. Reference Link
10:02 EDTLLYEli Lilly announces diabetes research partnership with University of Surrey
Subscribe for More Information
07:56 EDTLLYEli Lilly price target raised to $76 from $67 at Leerink
Subscribe for More Information
December 19, 2014
09:48 EDTLLYBiogen should be bought on weakness after Roche drug halted, says Evercore ISI
Subscribe for More Information
08:53 EDTLLYBiogen drug, trial differs from Roche Alzheimer's drug, says RBC Capital
Subscribe for More Information
05:39 EDTLLYEli Lilly, Adocia to co-develop BioChaperone Lispro
Subscribe for More Information
December 16, 2014
14:48 EDTLLYEli Lilly's CYRAMZA receives third FDA approval
Subscribe for More Information
December 15, 2014
16:33 EDTLLYEli Lilly raises quarterly dividend 2% to 50c per share
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use